{"name":"Escitalopram","slug":"escitalopram","kind":"substance","abbreviations":[],"systematic":null,"aliases":["(S)-Citalopram","S(+)-Citalopram","Cipralex","Seroplex","S-(+)-Citalopram","Esertia","(+)-Citalopram","Esitol","escitalopramum","(+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile"],"brands":[],"scraped":true,"has_structure":true,"cid":146570,"classes":[],"families":[{"name":"alkylbenzene","href":"/substituted/alkylbenzene"}],"physical":[{"label":"Molecular mass","value":"324.40 g/mol","copyable":false},{"label":"Melting point","value":"147-152C","copyable":false},{"label":"Solubility","value":"Sparingly soluble","copyable":false},{"label":"Predicted LogP","value":"3.2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>20</sub>H<sub>21</sub>FN<sub>2</sub>O","copyable":true},{"label":"IUPAC name","value":"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile","copyable":true},{"label":"SMILES","value":"CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F","copyable":true},{"label":"InChI","value":"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1","copyable":true},{"label":"InChIKey","value":"WSEQXVZVJXJVFP-FQEVSTJZSA-N","copyable":true},{"label":"CAS number","value":"128196-01-0","copyable":true},{"label":"UNII","value":"4O4S742ANY","copyable":true},{"label":"PubChem CID","value":"146570","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"~27–32 hours","copyable":false},{"label":"Metabolism","value":"Liver (CYP2C19, CYP3A4, CYP2D6)","copyable":false},{"label":"Excretion","value":"Urine (major; 8–10% unchanged), feces (minor)","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Escitalopram oxalate","name":"oxalate","slug":"escitalopram_oxalate","drawn":true},{"title":"Escitalopram hydrobromide","name":"hydrobromide","slug":"escitalopram_hydrobromide","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":"( + )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N06","description":"Psychoanaleptics"},{"code":"N06A","description":"Antidepressants"},{"code":"N06AB","description":"Selective serotonin reuptake inhibitors"},{"code":"N06AB10","description":""},{"code":"N06AB10","description":"Escitalopram"}],"mesh":[{"name":"Selective Serotonin Reuptake Inhibitors","id":"M0556972"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP2D6","mechanisms":["metabolism","inhibition","induction"],"partners":365,"contraindicated":15},{"target":"CYP3A4","mechanisms":["metabolism","induction","inhibition"],"partners":259,"contraindicated":4},{"target":"CYP2C19","mechanisms":["metabolism","inhibition","induction"],"partners":95,"contraindicated":2},{"target":"SLC6A4","mechanisms":["shared target"],"partners":60,"contraindicated":0},{"target":"AOX1","mechanisms":["metabolism"],"partners":3,"contraindicated":0}],"mechanism":"Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron. Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.  Escitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.","side_effects":null,"effects":null,"usernotes":[{"user":"a1ko","user_slug":"a1ko","external":false,"note":{"substance":"Escitalopram","composite":false,"routes":[{"name":"oral","dosage":"50mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"magnus","user_slug":"magnus","external":false,"note":{"substance":"Escitalopram","composite":false,"routes":[{"name":"Oral","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[{"id":"1bnwra0","title":"My mirtazapine trip","author":"actuallyaddie","score":11,"posted_on":"2024-03-26","url":"https://reddit.com/r/tripreports/comments/1bnwra0/my_mirtazapine_trip/"},{"id":"iza2ji","title":"Bad Experience - First Time","author":"DaddyHashbrowns","score":8,"posted_on":"2020-09-25","url":"https://reddit.com/r/tripreports/comments/iza2ji/bad_experience_first_time/"},{"id":"1bnwm4n","title":"I tripped on mirtazapine","author":"actuallyaddie","score":1,"posted_on":"2024-03-26","url":"https://reddit.com/r/tripreports/comments/1bnwm4n/i_tripped_on_mirtazapine/"},{"id":"iz9qn6","title":"Terrible Marijuana Experience","author":"Negative-Fox3535","score":1,"posted_on":"2020-09-25","url":"https://reddit.com/r/tripreports/comments/iz9qn6/terrible_marijuana_experience/"}],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"Brazil","status":"C1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[5]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[6]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Escitalopram"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/146570"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q423757"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01175"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1508"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A36791"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=128196-01-0"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0005028"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D07913"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8048440"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Escitalopram"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/4O4S742ANY"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 146570, Escitalopram. Accessed November 22, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/146570>https://pubchem.ncbi.nlm.nih.gov/compound/146570</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Escitalopram. UNII: 4O4S742ANY. Global Substance Registration System. Accessed November 22, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4O4S742ANY>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4O4S742ANY</a>","Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration. 21 June 2022. <a href='https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017'>https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Lexapro- escitalopram tablet, film coated; Lexapro- escitalopram solution. DailyMed. 17 November 2023. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13bb8267-1cab-43e5-acae-55a4d957630a'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13bb8267-1cab-43e5-acae-55a4d957630a</a>","Active substance(s): escitalopram. List of nationally authorised medicinal products. September 2022. <a href='https://www.ema.europa.eu/documents/psusa/escitalopram-list-nationally-authorised-medicinal-products-psusa/00001265/202112_en.pdf'>https://www.ema.europa.eu/documents/psusa/escitalopram-list-nationally-authorised-medicinal-products-psusa/00001265/202112_en.pdf</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 09:34:31","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 09:34:27","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 09:34:27","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 09:34:29","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 09:34:27","note":"hmdb.ca refused automated access to HMDB0005028"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 09:34:31","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 09:34:27","note":null},{"source":"reddit","status":"ok","fetched_at":"2026-11-20 09:34:27","note":null},{"source":"sider","status":"missing","fetched_at":"2026-11-20 09:34:27","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 09:34:27","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 09:34:28","note":null}],"description":"Escitalopram is a  substance."}